{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T04:11:59Z","timestamp":1749615119453,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biotherapy"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1023\/a:1007932130188","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T12:13:40Z","timestamp":1040559220000},"page":"15-20","source":"Crossref","is-referenced-by-count":11,"title":["Use of recombinant interferon gamma in pediatric patients with advanced juvenile chronic arthritis"],"prefix":"10.1007","volume":"11","author":[{"given":"C.","family":"Coto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Varela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"del Rosario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"L\u00f3pez-Saura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"143456_CR1","first-page":"11","volume":"19","author":"D. E. Furst","year":"1992","unstructured":"Furst D E. Toxicity of antirheumatic medications in children with juvenile arthritis. J Rheumatol 1992;19 (Suppl. 33): 11\u201315.","journal-title":"J Rheumatol"},{"issue":"12","key":"143456_CR2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0167-5699(87)90212-X","volume":"8","author":"J Brauning","year":"1987","unstructured":"Brauning J. Interferons and rheumatoid arthritis: insight into interferon biology. Immunol Today 1987;8 (12):372\u2013374.","journal-title":"Immunol Today"},{"key":"143456_CR3","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1055\/s-2008-1069083","volume":"110","author":"HJ Obert","year":"1985","unstructured":"Obert HJ and Hofschneider PH. Interferon for chronic polyarthritis. Positive effect in clinical evaluation. Deutsche Med Wochenschr 1985; 110: 1766\u20131769.","journal-title":"Deutsche Med Wochenschr"},{"key":"143456_CR4","first-page":"92","volume":"45","author":"M Seitz","year":"1986","unstructured":"Seitz M, Manz G, Franke M. Use of recombinant human interferon gamma in patients with rheumatoid arthritis. Z Rheumatol 1986; 45: 92\u201399.","journal-title":"Z Rheumatol"},{"key":"143456_CR5","first-page":"S115","volume":"30","author":"GS Firestein","year":"1987","unstructured":"Firestein GS, Weisman MH and Zvaifler NJ. Parenteral interferon gamma in rheumatoid arthritis. Effect on disease activity and peripheral blood monocytes (abstr). Arthritis Rheum 1987; 30: S115.","journal-title":"Arthritis Rheum"},{"key":"143456_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00271840","volume":"8","author":"EM Lemmel","year":"1988","unstructured":"Lemmel EM, Brackertz D, Franke M, et al. Results of multi-center placebo controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon gamma. Rheumatol Internat 1988; 8: 87\u201393.","journal-title":"Rheumatol Internat"},{"key":"143456_CR7","first-page":"570","volume":"15","author":"EM Veys","year":"1988","unstructured":"Veys EM, Mielants H, Verbruggen G, et al. Interferon gamma in rheumatoid arthritis. A double-blind study comparing human recombinant interferon gamma with placebo. J Rheumatol, 1988; 15: 570\u2013574.","journal-title":"J Rheumatol"},{"key":"143456_CR8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/anr.1780320805","volume":"32","author":"GW Cannon","year":"1989","unstructured":"Cannon GW, Pincus SH, Emkey RD, et al. Double-blind trial of recombinant gamma interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1989; 32: 964\u2013973.","journal-title":"Arthritis Rheum"},{"key":"143456_CR9","first-page":"S131","volume":"32","author":"?KP Machold","year":"1989","unstructured":"Machold KP, Smolen JS. Recombinant human gamma interferon in the treatment of rheumatoid arthritis. Double blind placebo-controlled crossover study (abstr). Arthritis Rheum 1989; 32: S131.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"143456_CR10","first-page":"101","volume":"48","author":"S Meske","year":"1989","unstructured":"Meske S, Weber S, Wirzberger M, and Peter H Therapy of rheumatoid arthritis with recombinant gamma interferon. Z Rheumatol 1989; 48(2): 101\u2013102.","journal-title":"Z Rheumatol"},{"key":"143456_CR11","first-page":"304","volume":"17","author":"GW Cannon","year":"1990","unstructured":"Cannon GW, Emkey RD, Denes A, et al. Prospective two-year follow-up of recombinant interferon gamma in rheumatoid arthritis. J Rheumatol 1990; 17: 304\u2013310.","journal-title":"J Rheumatol"},{"issue":"5","key":"143456_CR12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/anr.1780320520","volume":"32","author":"W Pernice","year":"1989","unstructured":"Pernice W, Schumann A, Dippel J, Suske J, Vegel P. Therapy for systemic juvenile rheumatoid arthritis with gamma-interferon: a pilot study of nine patients. Arthritis Rheum 1989; 32(5): 643\u2013646.","journal-title":"Arthritis Rheum"},{"key":"143456_CR13","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1089\/jir.1991.11.243","volume":"11","author":"C Coto","year":"1991","unstructured":"Coto C, Varela G, L\u00f3pez-Saura P, Hern\u00e1ndez V, Valle J. Use of recombinant gamma interferon in two pediatric patients with Juvenile Rheumatoid Arthritis (JRA). J Interferon Res 1991; 11(suppl1): S243.","journal-title":"J Interferon Res"},{"key":"143456_CR14","first-page":"S137","volume":"13","author":"C Coto","year":"1993","unstructured":"Coto C, Varela G, Hern\u00e1ndez V, L\u00f3pez-Saura P Use of recombinant gamma interferon in six pediatric patients with Juvenile Rheumatoid Arthritis (JRA). J Interferon Res 1993; 13 (suppl 1): S137.","journal-title":"J Interferon Res"},{"key":"143456_CR15","unstructured":"de la Fuente J, Silva A, P\u00e9rez G, et al. Expresi\u00f3n del gen del interfer\u00f3n gamma humano en E. coli, in Proceedings of the II Cuban Seminar on Interferon-I Cuban Seminar on Biotechnology, Part II. Instituto de Cooperaci\u00f3n Iberoamericana, Madrid, La Habana, 1986, pp 740\u2013751."},{"key":"143456_CR16","unstructured":"Mu\u00f1oz-G\u00f3mez J, Artritis reumatoidea, in Reumatologa Cl\u00ednica, Rot\u00e9s-Querol J eds, ESPAXS, Barcelona, 1983, pp 75\u201397."},{"key":"143456_CR17","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1056\/NEJM198605153142001","volume":"314","author":"EJ Brewer","year":"1986","unstructured":"Brewer EJ, Giannini EH, Kuzmina N, Alekseev L. Penicillamide and hydroxycholoquine in the treatment of severejuvenile rheumatoid arthritis: results of the USA-USSR double-blind placebo-controlled trial. N Eng J Med 1986; 314: 1269\u20131276.","journal-title":"N Eng J Med"},{"key":"143456_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.1780310103","volume":"31","author":"EH Giannini","year":"1988","unstructured":"Giannini EH, Brewer EJ, Kuzmina N, Alekseev, L Shokh BP. Characteristics of responders and nonresponders to slow acting anti-rheumatic drugs in juvenile rheumatoid arthritis. Arthritis Rheum 1988; 31: 15\u201320.","journal-title":"Arthritis Rheum"},{"key":"143456_CR19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/art.1780330402","volume":"33","author":"EH Giannini","year":"1990","unstructured":"Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Wallin B. Auranofin in the treatment of juvenile rheumatoid arthritis: results ofthe USA-USSR double-blind placebo-controlled trial. Arthritis Rheum 1990; 33: 466\u2013476.","journal-title":"Arthritis Rheum"},{"key":"143456_CR20","first-page":"427","volume-title":"Principles and Medical Applications","author":"JR Quesada","year":"1992","unstructured":"Quesada JR. Toxicity and side effects of interferons, in Interferon. Principles and Medical Applications, Baron S, Coppenhaver DH, Dianzani F et al. eds. University of Texas Medical Branch, Galveston, 1992, pp. 427\u2013432."},{"key":"143456_CR21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","volume":"14","author":"M Feldmann","year":"1996","unstructured":"Feldmann M, Brennan FM, Maini RN. Role of cytokines in Rheumatoid arthritis. Ann Rev Immunol 1996; 14: 397\u2013440.","journal-title":"Ann Rev Immunol"},{"key":"143456_CR22","first-page":"341","volume-title":"Principles and Medical Applications","author":"DO Adams","year":"1992","unstructured":"Adams DO. Regulation of macrophage function by interferon gamma, in Interferon. Principles and Medical Applications, Baron S, Coppenhaver DH, Dianzani F et al. eds. University of Texas Medical Branch, Galveston, 1992, pp. 341\u2013351."},{"key":"143456_CR23","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.162.5.1645","volume":"162","author":"MJ Skoskiewicz","year":"1985","unstructured":"Skoskiewicz MJ, Covin RB, Schneeberger EE, Russell PS. Widespread and selective induction of major histocompatibility complex-determined antigens in vivoby Gamma interferon. J Exptl Med 1985; 162: 1645\u20131664.","journal-title":"J Exptl Med"},{"key":"143456_CR24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(96)07524-1","volume":"349","author":"DH Adams","year":"1997","unstructured":"Adams DH, Lloyd AR. Chemokines: leukocyte recruitment and activation cytokines. Lancet 1997; 349: 490\u2013495.","journal-title":"Lancet"},{"key":"143456_CR25","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.4049\/jimmunol.144.9.3347","volume":"140","author":"GS Firestein","year":"1990","unstructured":"Firestein GS, Alvaro-Gracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990; 140: 3347\u20133352.","journal-title":"J Immunol"},{"issue":"5","key":"143456_CR26","first-page":"809","volume":"23","author":"N al-Janadi","year":"1996","unstructured":"al-Janadi N; al-Dalaan A, al-Balla-S; Raziuddin S. CD4+ T cell inducible immunoregulatory cytokine response in rheumatoid arthritis. J Rheumatol 1996; 23(5): 809\u2013814.","journal-title":"J Rheumatol"},{"issue":"6","key":"143456_CR27","first-page":"1020","volume":"20","author":"G Verbruggen","year":"1993","unstructured":"Verbruggen G, Malfait AM, Veys EM, Gyselbrecht L, Lambert J, Almqvist KF, Influence of interferon gamma on isolated chondrocytes from human articular cartilage. Dose dependent inhibition of cell proliferation and proteoglycan synthesis. J Rheumatol 1993; 20(6): 1020\u20131026.","journal-title":"J Rheumatol"},{"issue":"1","key":"143456_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0167-4889(88)90042-0","volume":"968","author":"VM Kahari","year":"1988","unstructured":"Kahari VM, Heino J, Vuorio T, V uorio E. Interferon alpha and interferon gamma reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture. Biochi Biophys Acta 1988; 968 (1): 45\u201350.","journal-title":"Biochi Biophys Acta"},{"key":"143456_CR29","first-page":"129","volume-title":"Concepts Immunopathol","author":"GS Firestein","year":"1992","unstructured":"Firestein GS. Cytokines in autoimmune diseases, in Clinical and Molecular Aspects of Autoimmune Diseases. Concepts Immunopathol. Cruse JM, Lewis RE Jr eds, Karger, Basel, 1992, vol. 8, pp 129\u2013160."}],"container-title":["Biotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007932130188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007932130188\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007932130188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T17:38:21Z","timestamp":1749577101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007932130188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["143456"],"URL":"https:\/\/doi.org\/10.1023\/a:1007932130188","relation":{},"ISSN":["0921-299X","1573-8280"],"issn-type":[{"type":"print","value":"0921-299X"},{"type":"electronic","value":"1573-8280"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}